Coronavirus research: Johnson and Johnson and Eli Lilly pause trials amid safety concerns

44

Yahoo Finance’s Anjalee Khemlani reports on Johnson and Johnson pausing it’s late stage vaccine trials due to a participant contracting an unexplained illness and Eli Lilly pausing its antibody trials due to potential concerns.
#Johnson&Johnson…